International Conference
Tumour biomarkers: From discovery to clinical applications




The introduction of tumor biomarkers (TB) has revolutionized the clinical practice of oncology. TB are molecules that represent biological alterations produced directly by the tumor or by the body’s response to the tumor.The ideal biomarker for clinical use should have easy means of measurement, high accuracy for its intended outcome, and should provide improvement of decision-making.

The "Tumour biomarkers: From discovery to clinical applications" conference covers a wide range of apsects regarding the state-of-the-art in cancer biomarker research though 8 sessions:

Session 1: miRNAs as emerging cancer biomarkers


Session 2: Circulating tumor cells


Session 3: Translating molecular pathways into novel cancer biomarkers


Session 4: Novel technological advances in biomarker discovery


Session 5: Biological tumor markers of female reproductive organ malignancies


Session 6: The future of cancer biomarkers


Session 7: Novel approaches for urologic tumor biomarker discovery


Session 8: Novel biomarkers for leukemia and lymphoma